BORTEZOMIB (BORTEZOMIB) — FDA Approval ANDA209622 (MSN)
BORTEZOMIB (BORTEZOMIB) — FDA Approval ANDA209622 (MSN) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: BORTEZOMIB; Active ingredients: BORTEZOMIB; Application number: ANDA209622.
| Brand name | BORTEZOMIB |
|---|---|
| Active ingredients | BORTEZOMIB |
| Application number | ANDA209622 |
| Sponsor | MSN |
| Dosage form | INJECTABLE |
| Route | INTRAVENOUS, SUBCUTANEOUS |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20220726 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →